Affitech cancer, infectious, antibodies news

Affitech said the Danish Financial Supervisory Authority is reporting the company to the Danish police for violating major shareholder possession flagging rules on five occasions and for lack of announcements on raised capital in June and July, 2009. According to Affitech, the violations relate to the company's 2009 reverse merger with Pharmexa A/S (see BioCentury, June 29, 2009). ...